Point-of-care EEG in the Pediatric Emergency Department
Launched by UNIVERSITY CHILDREN'S HOSPITAL, ZURICH · Jun 9, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to monitor brain activity in children who may be having serious seizure episodes or have unclear reasons for their decreased awareness. Researchers want to see if a simplified type of brain scan, known as a point-of-care EEG, is as effective as the traditional EEG used in outpatient settings. This could help doctors make quicker decisions in emergency situations, especially for children experiencing status epilepticus, which is when a seizure lasts too long or occurs repeatedly without recovery in between.
To participate in this trial, children must be patients in the pediatric emergency department with unexplained impaired consciousness or ongoing seizures. They should be able to have a parent or guardian provide consent, or there are special procedures in place for emergency situations. In addition, children who are already diagnosed with epilepsy and are undergoing regular EEG monitoring in an outpatient clinic may also be eligible. Participants in the trial can expect to have their brain activity monitored using both the new simplified EEG and the standard EEG, helping researchers understand which method works better in different settings.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- General:
- PED:
- • Pediatric patients with unexplained impaired consciousness, suspicion of NCSE, active SE presenting to the PED
- • Informed consent of patient of parents/persons responsible, if possible, otherwise emergency situation procedure (according to national regulations for research in emergency situations)
- CLINIC:
- • Informed consent as documented by signature
- • Pediatric patients undergoing cEEG in the outpatient epilepsy clinics
- • Either suspected/ to rule out epilepsy or established diagnosis of epilepsy
- Exclusion Criteria:
- PED:
- • AMS of known etiology or another diagnosis
- • Declined informed consent
- CLINIC:
- • Failure to provide signed informed consent
- • Changes in health condition which might interfere with the EEG recording.
About University Children's Hospital, Zurich
The University Children's Hospital Zurich is a leading academic medical institution dedicated to advancing pediatric healthcare through innovative research and clinical excellence. Affiliated with the University of Zurich, the hospital specializes in a wide range of pediatric disciplines, offering comprehensive care to children and adolescents. As a prominent sponsor of clinical trials, the institution is committed to exploring new therapies and improving treatment protocols, ensuring that young patients benefit from the latest advancements in medicine. With a focus on collaboration, the hospital engages in partnerships with researchers, healthcare professionals, and pharmaceutical companies to drive impactful studies that enhance the health and well-being of children globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zürich, , Switzerland
Patients applied
Trial Officials
Georgia Ramantani, MD, PhD
Principal Investigator
University Children's Hospital, Zurich
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials